The Japanese biochemist found in the 1970s that cholesterol-lowering drugs lowered the LDL, or “bad” cholesterol, level in the blood.
Tag: Merck & Company Inc
Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatment
New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations.
The Push for a Better Dengue Vaccine Grows More Urgent
A public research institute in Brazil has proved a new shot protects against the disease, but can’t make it fast enough to stop the huge outbreak sweeping Latin America.
Seeking Covid Pills, Poor Nations Fear Repeat of AIDS Crisis
The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that evoke the H.I.V. epidemic.
Merck’s Covid Pill Might Pose Risks for Pregnant Women
Some laboratory studies suggest that molnupiravir can insert errors in DNA, which could in theory harm a developing fetus, sperm cells or children.
F.D.A. Advisers Endorses Merck’s Covid Pill for High-Risk Adults
The drug, molnupiravir, could be authorized within days for patients at high risk of severe illness.
Merck Says Its Covid Pill Is Less Effective in a Final Analysis
The drug, molnupiravir, reduced the risk of hospitalization and death in high-risk Covid patients by 30 percent. An earlier analysis had found a 50 percent reduction.
U.S. to Buy Enough of Pfizer’s Covid Antiviral Pills for 10 Million People
The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the Delta variant.
The U.K. Approves Merck’s Covid Pill
The British authorities said that the antiviral drug was “safe and effective” in reducing the risk of hospitalization and death for those at increased risk of severe symptoms.
Merck Will Share Formula for Its Covid Pill With Poor Countries
The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.